BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36708700)

  • 1. Design, synthesis, and biological evaluation of indolin-2-one derivatives as novel cyclin-dependent protein kinase 8 (CDK8) inhibitors.
    Hsu JY; Hsu KC; Sun C; Chou CH; Lin TE; Sung TY; Tseng HJ; Yen SC; Yang CR; Huang WJ
    Biomed Pharmacother; 2023 Mar; 159():114258. PubMed ID: 36708700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The study of a novel CDK8 inhibitor E966-0530-45418 that inhibits prostate cancer metastasis in vitro and in vivo.
    Ho TY; Sung TY; Pan SL; Huang WJ; Hsu KC; Hsu JY; Lin TE; Hsu CM; Yang CR
    Biomed Pharmacother; 2023 Jun; 162():114667. PubMed ID: 37037092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
    Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
    J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tannic acid attenuates TGF-β1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-β signaling in lung epithelial cells.
    Pattarayan D; Sivanantham A; Krishnaswami V; Loganathan L; Palanichamy R; Natesan S; Muthusamy K; Rajasekaran S
    J Cell Physiol; 2018 Mar; 233(3):2513-2525. PubMed ID: 28771711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
    Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH
    Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL9 Regulates TGF-β1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells.
    O'Beirne SL; Walsh SM; Fabre A; Reviriego C; Worrell JC; Counihan IP; Lumsden RV; Cramton-Barnes J; Belperio JA; Donnelly SC; Boylan D; Marchal-Sommé J; Kane R; Keane MP
    J Immunol; 2015 Sep; 195(6):2788-96. PubMed ID: 26268659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of AHNAK nucleoprotein 2 alleviates pulmonary fibrosis by downregulating the TGF-β1/Smad3 signaling pathway.
    Zhu D; Zhang Q; Li Q; Wang G; Guo Z
    J Gene Med; 2022 Sep; 24(9):e3442. PubMed ID: 35882062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinase inhibitors fail to induce mesenchymal-epithelial transition in fibroblasts from fibrotic lung tissue.
    Xu X; Wan X; Geng J; Li F; Wang C; Dai H
    Int J Mol Med; 2013 Aug; 32(2):430-8. PubMed ID: 23760654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation.
    Chen YL; Zhang X; Bai J; Gai L; Ye XL; Zhang L; Xu Q; Zhang YX; Xu L; Li HP; Ding X
    Cell Death Dis; 2013 Jun; 4(6):e665. PubMed ID: 23764846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA MKLN1 promotes epithelial-mesenchymal transition in pulmonary fibrosis by regulating the miR-26a/b-5p/CDK8 axis in human alveolar epithelial cells and mice models.
    Zhu Y; Meng X; Zhu X; Zhang J; Lv H; Wang F; Wang J; Chen C; Chen M; Wang D; Jin W; Tian R; Wang R
    Arch Toxicol; 2024 May; 98(5):1399-1413. PubMed ID: 38460002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment.
    Lin TE; Yang CR; Chou CH; Hsu JY; Chao MW; Sung TY; Hsieh JH; Huang WJ; Hsu KC
    Biomed Pharmacother; 2022 Feb; 146():112459. PubMed ID: 34953394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
    Qian W; Cai X; Qian Q; Zhang W; Wang D
    J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis-associated protein 1 promotes epithelial-mesenchymal transition in idiopathic pulmonary fibrosis by up-regulating Snail expression.
    Qian W; Cai X; Qian Q; Zhang W; Tian L
    J Cell Mol Med; 2020 Jun; 24(11):5998-6007. PubMed ID: 32187849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Synthesis of a 2-Amino-pyridine Derivative as a Potent CDK8 Inhibitor for Anti-colorectal Cancer Therapy.
    Yan YY; Zhang XX; Xiao Y; Shen XB; Jian YJ; Wang YM; She ZH; Liu MM; Liu XH
    J Med Chem; 2022 Oct; 65(19):13216-13239. PubMed ID: 36126227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway.
    Ruan H; Gao S; Li S; Luan J; Jiang Q; Li X; Yin H; Zhou H; Yang C
    Molecules; 2021 May; 26(9):. PubMed ID: 34068694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
    Kim S; Lim JH; Woo CH
    Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide Inhibits TGF-β1-induced Epithelial to Mesenchymal Transition in Alveolar Epithelial Cells via Smad-Dependent and Smad-Independent Signaling Pathways.
    Zhou XL; Xu P; Chen HH; Zhao Y; Shen J; Jiang C; Jiang S; Ni SZ; Xu B; Li L
    Sci Rep; 2017 Nov; 7(1):14727. PubMed ID: 29116196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel CDK8 inhibitor with poly-substituted pyridine core: Discovery and anti-inflammatory activity evaluation in vivo.
    Chen X; Yan Y; Cheng X; Zhang Z; He C; Wu D; Zhao D; Liu X
    Bioorg Chem; 2023 Apr; 133():106402. PubMed ID: 36791618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
    Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of CDK 8/19 inhibitors: Discovery of novel and selective CDK8/19 dual inhibitors and elimination of their CYP3A4 time-dependent inhibition potential.
    Fujimoto J; Hirayama T; Hirata Y; Hikichi Y; Murai S; Hasegawa M; Hasegawa Y; Yonemori K; Hata A; Aoyama K; Cary DR
    Bioorg Med Chem; 2017 Jun; 25(12):3018-3033. PubMed ID: 28392276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.